Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
NeoImmuneTech
Avenzo Therapeutics, Inc.
Auricula Biosciences Inc.
DualityBio Inc.
Inhibrx Biosciences, Inc
Tanabe Pharma America, Inc.
CRISPR Therapeutics
Turning Point Therapeutics, Inc.
Marengo Therapeutics, Inc.
Hoffmann-La Roche
Numab Therapeutics AG
Intensity Therapeutics, Inc.
Iovance Biotherapeutics, Inc.
Simcha IL-18, Inc.
Cancer Research UK
Evopoint Biosciences Inc.
Bristol-Myers Squibb
Kineta Inc.
Ludwig Institute for Cancer Research
Vaccinex Inc.
Genocea Biosciences, Inc.
University of Florida
AVEO Pharmaceuticals, Inc.